UNSPSC 51241110: Latanoprost

This classification denotes a prostaglandin analogue and anti-glaucoma agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Z5B6HVF6O. European Medicines Agency schedules Latanoprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08409MIG. Latanoprost generally arises in the molecular formula C26H40O5.

UNSPSC 51241110 Latanoprost, a Commodity code, identifies a prostaglandin analog ophthalmic medication used to treat elevated intraocular pressure and glaucoma. State and local governments procure latanoprost primarily through health department pharmaceutical purchasing, correctional facility medical supply contracts, and public health clinic formularies. The medication appears in solicitations from state departments of health, county health systems, municipal clinics, and corrections departments that maintain in-house pharmacy operations or contracted pharmacy benefit management agreements.

The source provides no recent state and local contract opportunities tagged to this code. Without posted RFPs, RFQs, ITBs, or IFBs identifying latanoprost procurement activity, geographic concentration and issuing-body frequency cannot be determined from current market signals. Firms pursuing this code should monitor state health department pharmaceutical cooperative purchasing vehicles and corrections-system medical supply RFQs, which often bundle generic medications including latanoprost into broader formulary or GPO contracts rather than issuing single-drug solicitations.